Gilead's Latest Bolt-On Buys Point To A New Way Of Approaching Drug DevelopmentSeeking Alpha • 06/26/19
Gilead strikes deal with Nurix Therapeutics to tackle disease-causing proteinsMarket Watch • 06/19/19
3 Big Drugmakers Most Likely to Make Acquisitions After Pfizer's Surprise DealThe Motley Fool • 06/18/19
Gilead Hopes To Continue Sales Expansion Of Yescarta - Results From KTE-X19 Step In The Right DirectionSeeking Alpha • 06/11/19